Journal of the American Academy of Dermatology
Volume 62, Issue 3 , Pages 415-417 , March 2010

Commentary: The illusory tinea unguium cure

  • C. Ralph Daniel III, MD

      Affiliations

    • University of Mississippi Medical Center, Jackson, Mississippi
    • ,
  • Nathaniel J. Jellinek, MD

      Affiliations

    • Department of Dermatology, the Warren Alpert School of Medicine at Brown University, Providence, Rhode Island
    • Corresponding Author InformationReprint requests: Nathaniel J. Jellinek, MD, 1672 S County Trail, Suite 101, East Greenwich, RI 02818.

References 

  1. Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol. 2003;149(Suppl):1–4
  2. Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi. Mycoses. 1989;32:609–619
  3. Gupta AK, Jain HC, Lynde CW, Watteel GN, Summerbell RC. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada–a multicenter survey of 2001 patients. Int J Dermatol. 1997;36:783–787
  4. Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol. 2000;43(Suppl):S70–S80
  5. Piraccini BM, Sisti A, Tosti A. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungals. J Am Acad Dermatol. 2010;62:411–414
  6. Zaias N, Rebell G. The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. Arch Dermatol. 2004;140:691–695
  7. Warshaw EM, Fett DD, Bloomfield HE, Grill JP, Nelson DB, Quintero V, et al. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial. J Am Acad Dermatol. 2005;53:578–584
  8. Gupta AK, Lynch LE, Kogan N, Cooper EA. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis. J Eur Acad Dermatol Venereol. 2009;23:256–262
  9. Gupta AK, Lynde CW, Konnikov N. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol. 2001;44:485–491
  10. Cribier BJ, Paul C. Long-term efficacy of antifungals in toenail onychomycosis: a critical review. Br J Dermatol. 2001;145:446–452
  11. Schram SE, Warshaw EM. Costs of pulse versus continuous terbinafine for onychomycosis. J Am Acad Dermatol. 2007;56:525–527
  12. Zaias N, Tosti A, Rebell G, Morelli R, Bardazzi F, Bieley H, et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol. 1996;34:302–304
  13. Burkhart CN, Burkhart CG, Gupta AK. Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm. J Am Acad Dermatol. 2002;47:629–631
  14. Gupta AK, Ricci MJ. Diagnosing onychomycosis. Dermatol Clin. 2006;24:365–369
  15. Vural E, Winfield HL, Shingleton AW, Horn TD, Shafirstein G. The effects of laser irradiation on Trichophyton rubrum growth. Lasers Med Sci. 2008;23:349–353
  16. Murdan S. Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Deliv. 2008;5:1267–1282
  17. Borovoy M, Tracy M. Noninvasive CO2 laser fenestration improves treatment of onychomycosis. Clin Laser Mon. 1992;10:123–124
  18. Piraccini BM, Rech G, Tosti A. Photodynamic therapy of onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol. 2008;59(Suppl):S75–S76
  19. Watanabe D, Kawamura C, Masuda Y, Akita Y, Tamada Y, Matsumoto Y. Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol. 2008;144:19–21
  20. Donnelly RF, McCarron PA, Lightowler JM, Woolfson AD. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J Control Release. 2005;103:381–392
  21. Kamp H, Tietz HJ, Lutz M, Piazena H, Sowyrda P, Lademann J, et al. Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses. 2005;48:101–107
  22. Arrese JE, Pierard-Franchimont C, Pierard GE. Facing up to the diagnostic uncertainty and management of onychomycoses. Int J Dermatol. 1999;38(Suppl):1–6
  23. Fletcher CL, Hay RJ, Smeeton NC. Observer agreement in recording the clinical signs of nail disease and the accuracy of a clinical diagnosis of fungal and non-fungal nail disease. Br J Dermatol. 2003;148:558–562
  24. Gupta AK, Tu LQ. Onychomycosis therapies: strategies to improve efficacy. Dermatol Clin. 2006;24:381–386
  25. Gupta AK, Baran R. Ciclopirox nail lacquer solution 8% in the 21st century. J Am Acad Dermatol. 2000;43(Suppl):S96–102
  26. Daniel CR, Jellinek NJ. The pedal fungus reservoir. Arch Dermatol. 2006;142:1344–1346
  27. Warshaw EM, St Clair KR. Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%. J Am Acad Dermatol. 2005;53:717–720
  28. Gupta AK, Ryder JE. How to improve cure rates for the management of onychomycosis. Dermatol Clin. 2003;21:499–505vii
  29. Gupta AK, Konnikov N, Lynde CW. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. J Am Acad Dermatol. 2001;44:479–484
  30. Arai H, Arai T, Nakajima H, Haneke E. Formable acrylic treatment for ingrowing nail with gutter splint and sculptured nail. Int J Dermatol. 2004;43:759–765

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)01145-1

doi: 10.1016/j.jaad.2009.09.001

Journal of the American Academy of Dermatology
Volume 62, Issue 3 , Pages 415-417 , March 2010

Article Tools